Key Takeaways
The FDA granted De Novo authorization on July 22 to Johnson & Johnson's Ottava, the first table-integrated soft-tissue robotic surgical system.
Ottava builds four robotic arms into the operating table, cutting the physical footprint 30 to 50 percent versus cart or boom-mounted robots.
The clearance covers general-surgery procedures like gastric bypass, gallbladder removal, and hernia repair, with a limited US launch to follow.
The Food and Drug Administration granted De Novo authorization on July 22 to Ottava, Johnson & Johnson's robotic surgical system, the company announced. J&J called it the first soft-tissue surgical robot to build its arms directly into the operating table.
Most surgical robots roll up to the table as separate carts or booms. Ottava puts four arms into the table itself, which the company says cuts the system's physical footprint by 30 to 50 percent. In an operating room where space and setup time are real constraints, that is the pitch.
The authorization covers a list of general-surgery procedures, including Roux-en-Y gastric bypass, gastrectomy, gallbladder removal, splenectomy, gastric sleeve, appendectomy, and hiatal hernia repair. J&J said it will launch commercially with a small group of US customers first, then work toward more procedures and other countries.
The move puts J&J into direct competition with Intuitive Surgical, whose da Vinci system has defined robotic surgery for two decades. A second serious platform with a different form factor is the kind of shift that changes pricing and access over time, not overnight. Hospitals have wanted a credible second option for years, both to negotiate on price and to avoid depending on a single vendor for a tool this central to the operating room.
Robots are moving deeper into medicine on every front, and the money behind them keeps climbing. WYDE has covered humanoid robots performing live surgery for the first time at UC San Diego and a record $18.8 billion in robotics funding as machines move into food and care. Ottava is that trend reaching the operating table with a regulator's stamp. Worth watching how fast hospitals adopt it.
People Also Ask
What is Johnson & Johnson's Ottava?
Ottava is a robotic surgical system with four arms built into the operating table, authorized by the FDA in July 2026 for soft-tissue general surgery.
How is Ottava different from other surgical robots?
Its arms are integrated into the table rather than mounted on separate carts or booms, cutting the system's footprint by 30 to 50 percent.
What procedures is Ottava cleared for?
It is cleared for general-surgery procedures including gastric bypass, gastrectomy, gallbladder removal, appendectomy, and hiatal hernia repair.
Who competes with Ottava in robotic surgery?
Intuitive Surgical's da Vinci system has led robotic surgery for two decades and is Ottava's main competitor.
Sources: Johnson & Johnson, MassDevice.